Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Extended clinical study of DSP-1958

Trial Profile

Extended clinical study of DSP-1958

Phase of Trial: Phase I

Latest Information Update: 10 Oct 2018

At a glance

  • Drugs Thiotepa (Primary)
  • Indications Brain cancer; Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 04 Oct 2018 Planned number of patients changed from 50 to 80.
    • 04 Oct 2018 Planned End Date changed from 30 Nov 2018 to 31 Oct 2019.
    • 09 Apr 2018 Planned number of patients changed from 30 to 50.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top